Catalysis and function of the p38α·MK2a signaling complex

Biochemistry

Volumn 43, Issue 31, 2004, Pages 9950-9960

  Lukas, Susan M ^a   Kroe, Rachel R ^a   Wildeson, Jessi ^a   Peet, Gregory W ^a   Frego, Lee ^a   Davidson, Walter ^a   Ingraham, Richard H ^a   Pargellis, Christopher A ^a   Labadia, Mark E ^a   Werneburg, Brian G ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; COMPLEXATION; DISEASE CONTROL; ENZYMES; RESONANCE; SIGNALING;

CYTOKINES; TIGHT-BINDING INHIBITORS;

BIOCHEMISTRY;

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; CALORIMETRY; CARBOXY TERMINAL SEQUENCE; CATALYSIS; COMPLEX FORMATION; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME KINETICS; FLUORESCENCE; IMMUNOCHEMISTRY; ISOTHERM; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SURFACE PLASMON RESONANCE; THERMODYNAMICS;

ALTERNATIVE SPLICING; ANIMALS; CALORIMETRY; CATALYSIS; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; ISOENZYMES; KINETICS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 14; MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE; THERMODYNAMICS; ULTRACENTRIFUGATION;

EID: 3543060538     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049508v     Document Type: Article

References (40)

1. Hannigan, M. O., Zhan, L., Ai, Y., Kotlyarov, A., Gaestel, M., and Huang, C. K. (2001) Abnormal migration phenotype of mitogen-activated protein kinase-activated protein kinase 2-/- neutrophils in Zigmond chambers containing formyl-methionylleucyl-phenylalanine, J. Immunol. 167, 3953-3961.
2. Kotlyarov, A., Yannani, Y., Fritz, S., Laass, K., Telliez, J.-B., Pitman, D., Liu, L.-L., and Gaestel, M. (2002) Distinct cellular functions of MK2, Mol. Cell. Biol. 22, 4827-4835.
3. Wang, X., Xu, L., Wang, H., Young, P. R., Gaestel, M., and Feurstein, G. Z. (2002) Mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice, J. Biol. Chem. 277, 43968-43972.
4. Kontoyiannis, D., Boulougouris, G., Manoloukos, M., Armaka, M., Apostoloki, M., Pizarro, T., Kotlyarov, A., Forster, I., Flavell, R., Gaestel, M., Tsichlis, P., Cominelli, F., and Kollias, G. (2002) Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease, J. Exp. Med. 196, 1563-1574.
5. Lee, J. C., Kassis, S., Kumar, S., Badger, A., and Adams, J. L (1999) p38 mitogen-activated protein kinase inhibitor: mechanisms and therapeutic potentials, Pharmacol. Ther. 82, 389-397.
6. Allen, M., Svensson, L., Roach, M., Hambor, J., McNeish, J., and Gabel, C. A. (2000) Deficiency of the stress kinase p38α results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells, J. Exp. Med. 191, 859-870.
7. Lee, J. C., Badger, A. M., Griswold, D. E., Dunnington, D., Truneh, A., Votta, B., White, J. R., Young, P. R., and Bender, P. E. (1993) Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors, Ann. N.Y. Acad. Sci. 696, 149-170.
8. Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S., and Regan, J. (2002) Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site, Nat. Struct. Biol. 9, 268-272.
9. Pargellis, C., and Regan, J. R. (2003) Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis, Curr. Opin. Invest. Drugs 4, 566-571.
10. Dinarello, C. A. (1991) Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases, Curr. Opin. Immunol. 3, 941-948.
11. Feldmann, M., Brennan, F. M., and Maini, R. N. (1996) Role of cytokines in rheumatoid arthritis, Annu. Rev. Immunol. 14, 397-440.
12. Rankin, E. C., Choy, E. H., Kassimos, D., Kingsley, G. H., Sopwith, A. M., Isenberg, D. A., and Panayi, G. S. (1995) The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis, Br. J. Rheumatol. 34, 334-342.
13. Nuki, K. G., Bresnihan, B., Bear, M. B., and McCabe, D. (2002) Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placibo-controlled trial, Arthritis Rheum. 46, 2838-2846.
14. Stokoe, D., Campbell, D. G., Nakielny, S., Hidaka, H., Leevers, S. J., Marshall, C., and Cohen, P. (1992) MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase, EMBO J. 11, 3985-3994.
15. Stokoe, D., Caudwell, F. B., Cohen, P. T. W., and Cohen, P. (1993) The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2, Biochem. J. 296, 843-849.
16. Freshney, N. W., Rawlinson, L., Guesdon, F., Jones, E., Cowley, S., Hsuan, J., and Saklatvala, J. (1994) Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27, Cell 78, 1039-1049.
17. Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llamazares, A., Zamanillo, D., Hunt, T., and Nebreda, A. R. (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock protein, Cell 78, 1027-1037.
18. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R., and Lee, J. C. (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1, FEBS Lett. 364, 229-233.
19. Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H. D., and Gaestel, M. (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis, Nat. Cell Biol. 1, 94-97.
20. Neiniger, A., Kontoyiannis, D., Kotlyarov, A., Winzen, R., Eckert, R., Volk, H. D., Holtmann, H., Kollias, G., and Gaestel, M. (2002) MK2 targets AU-rich elements and regulates biosythesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels, J. Biol. Chem. 277, 3065-3068.
21. Mahtani, K. R., Brook, M., Dean, J. L., Sully, G., Saklatvala, J., and Clark, A. R. (2001) Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability, Mol. Cell. Biol. 21, 6461-6469.
22. Stoecklin, G., Stubbs, T., Kedersha, N., Wax, S., Rigby, W. F. C., Blackwell, T. K., and Anderson, P. (2004) MK2-induced tristetraprolin: 14-3-3 complexes prevent stress granule association and ARE-mRNA decay, EMBO J. 23, 1313-1324.
23. Ben-Levy, R., Hooper, S., Wilson, R., Peterson, H. F., and Marshall, C. J. (1998) Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2, Curr. Biol. 8, 1049-1057.
24. Engel, K., Kotlyarov, A., and Gaestel, M. (1998) Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation, EMBO J. 17, 3363-3371.
25. Tanoue, T., Adachi, M., Moriguchi, T., and Nishida, E. (2000) A conserved docking motif in MAP kinases common to substrates, activators and regulators, Nat. Cell Biol. 2, 110-116.
26. Tanoue, T., Maeda, R., Adachi, M., and Nishida, E. (2001) Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions, EMBO J. 20, 466-479.
27. Smith, J. A., Poteet-Smith, C. E., Lannigan, D. A., Freed, T. A., Zoltoski, A. J., and Sturgill, T. W. (2000) Creation of a stress-activated p90 ribosomal S6 kinase. The carboxyl-terminal tail of the MAPK-activated protein kinases dictates the signal transduction pathway in which they function, J. Biol. Chem. 275, 31588-31593.
28. Hawkins, J., Zheng, S., Frantz, B., and LoGrasso, P. (2000) p38 map kinase substrate specificity differs greatly for protein and peptide substrates, Arch. Biochem. Biophys. 382, 310-313.
29. Kumar, S., McDonnell, P. C., Gum, R. J., Hand, A. T., Lee, J. C., and Young, P. R. (1997) Novel homologues of CSB/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibtion by pyridinyl imidazoles, Biochem. Biophys. Res. Commun. 235, 533-538.
30. Gum, R. J., and Young, P. R. (1999) Identification of two distinct regions of p38 MAPK required for substrate binding and phosphorylation, Biochem. Biophys. Res. Commun. 266, 284-289.
31. Zu, Y.-L., Wu, F., Gilchrist, A., Ai, Y., Labadia, M. E., and Huang, C.-K. (1994) The primary structure of a human MAP kinase activated protein kinase 2, Biochem. Biophys. Res. Commun. 200, 1118-1124.
32. Zu, Y.-L., Ai, Y., and Huang, C.-K. (1995) Characterization of an autoinhibitory domain in human mitogen-activated protein kinase-activated protein kinase 2, J. Biol. Chem. 270, 202-206.
33. Ben-Levy, R., Leighton, I. A., Doza, Y. N., Attwood, P., Morrice, N., Marshall, C. J., and Cohen, P. (1995) Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2, EMBO J. 14, 5920-5930.
34. Neineinger, A., Theilemann, H., and Gaestel, M. (2001) FRET-based detection of different conformations of MK2, EMBO Rep. 21, 703-708.
35. Kroe, R. R., Regan, J., Proto, A., Peet, G. W., Roy, T., Landro, L. D., Fuschetto, N. G., Pargellis, C. A., and Ingraham, R. H. (2003) Thermal denaturation: a method to rank slow binding, high-affinity p38α MAP kinase inhibitors, J. Med. Chem. 46, 4669-4675.
36. Johnsson, B., Löfås, S., and Lindquist, G. (1991) Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors, Anal. Biochem. 198, 268-277.
37. Morelock, M. M., Ingraham, R. H., Betageri, R., and Jakes, S. (1995) Determination of receptor-ligand kinetic and equilibrium binding constants using surface plasmon resonance: application to the Lck SH2 domain and phosphotyrosyl peptides, J. Med. Chem. 38, 1309-1318.
38. Morelock, M. M., Pargellis, C. A., Graham, E. T., Lamarre, D., and Jung, G. (1995) Time-resolved ligand exchange reactions: kinetic models for competitive inhibitors with recombinant human renin, J. Med. Chem. 38, 1751-1761.
39. Chang, C.-I., Xu, B.-E., Akella, R., Cobb, M. H., and Goldsmith, E. J. (2002) Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b, Mol. Cell 9, 1241-1249.
40. Shi, Y., and Gaestel, M. (2002) In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance, Biol. Chem. 383, 1519-1536.